Tapentadol is partially metabolized because of the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with medication that increase or repress the exercise/expression of one or more of such enzymes, together with with substrates of those enzymes (on account of Competitors to the enzyme); some enzyme mediators/substrates https://pearle172ujw4.blogsvila.com/profile